Biovie BIVI
NASDAQ BIVI
$1.26 +0.02 (+1.61%)
At close: Oct 21, 2026 · 4:00 PM EDT

Biovie (BIVI) EBITDA (2021 - 2022)

Updated

Biovie (BIVI) reported EBITDA of -$5.63 million for fiscal Q3 2022 (quarter ended Mar 31, 2022), compared with -$2.89 million a year earlier.

Analysis

Biovie (BIVI) EBITDA (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 9.10 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 8.33 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 5.09 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -9.70 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 5.89 Bn
10 Biovie 9.06 Mn -58.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -5.63 Mn
Mar 31, 2021 -2.89 Mn
API Access

Biovie EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=BIVI&period=max&api_key=YOUR_API_KEY